Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-006082
Filing Date
2023-04-17
Accepted
2023-04-17 17:01:37
Documents
18

Document Format Files

Seq Description Document Type Size
1 DEF 14A capr-20230612xdef14a.htm   iXBRL DEF 14A 783339
2 GRAPHIC capr-20230612xdef14a_a002.jpg GRAPHIC 8333
3 GRAPHIC capr-20230612xdef14a_a010.jpg GRAPHIC 32200
4 GRAPHIC capr-20230612xdef14a_a011.jpg GRAPHIC 32055
5 GRAPHIC capr-20230612xdef14a_bg001.jpg GRAPHIC 94757
6 GRAPHIC capr-20230612xdef14a_bg002.jpg GRAPHIC 171729
  Complete submission text file 0001558370-23-006082.txt   1964372

Data Files

Seq Description Document Type Size
7 EX-101.SCH capr-20230612.xsd EX-101.SCH 3353
8 EX-101.LAB capr-20230612_lab.xml EX-101.LAB 3705
9 EX-101.PRE capr-20230612_pre.xml EX-101.PRE 3062
12 EXTRACTED XBRL INSTANCE DOCUMENT capr-20230612xdef14a_htm.xml XML 50976
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34058 | Film No.: 23824617
SIC: 2834 Pharmaceutical Preparations